What the label states, the lot delivers — net peptide mass, not gross powder weight, purity reported as measured rather than rounded up, and a Certificate of Analysis for every lot.
Net peptide mass, not powder weight; purity as measured, not rounded up; a COA per lot.
Net peptide + purity not rounded up. COA per lot.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Potent GHRP hexapeptide · GH-secretagogue research
Overview
Hexarelin (also known as Examorelin) is a synthetic hexapeptide growth hormone-releasing peptide (GHRP) developed by scientists at Mediolanum Farmaceutici/Europeptides (including Romano Deghenghi) as a modification of GHRP-6, and is among the most potent GH-releasing GHRPs studied to date. It stimulates pulsatile pituitary GH secretion by binding the growth hormone secretagogue receptor (GHS-R1a), and separately produces a partially GH-independent cardioprotective effect through a distinct binding site on the CD36 scavenger receptor expressed in cardiac and peripheral tissue (demonstrated in ischemia-reperfusion… Vialdyne releases Hexarelin Acetate as a lyophilized peptide against a ≥98% HPLC main-peak specification, supplied with a batch-specific Certificate of Analysis covering RP-HPLC purity, mass-spec identity, appearance, and water content. Lots are released only after the COA is on file.
Applications & buyer fit
GH-axis peptides ship to two main buyer types: compounding pharmacies dispensing under physician supervision, and research labs studying somatotropic-axis pharmacology. Pharmacies typically want sterile-filled vials with the full release packet (sterility, endotoxin, CCI); labs typically want loose-format lyophilized powder with sequence verification. Blends (the CJC-1295 / Ipamorelin combination is the canonical example) are usually co-lyophilized rather than solution-mixed for potency stability.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Sterile-filled vials are available with the full release packet (sterility, endotoxin, CCI); loose lyophilized powder ships with sequence verification.
Primary buyer fit: academic and contract research laboratories.
Specifications
Certificate of Analysis
Published released-batch COAs for Hexarelin Acetate, every lot HPLC-verified. These are previews — request the full high-resolution certificate for any lot.
VerifiedRequest full COA →Hexarelin Acetate
VD260428-HEX094 · 99.52%
VerifiedRequest full COA →Hexarelin Acetate
VD260428-HEX095 · 99.66%
Regulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
Hexarelin Acetate ships as white to off-white lyophilized powder with a batch-specific Certificate of Analysis reporting RP-HPLC purity (≥98%), mass-spec identity and sequence His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2, and appearance. Recommended storage: -20°C; reconstituted 2–8°C. Supplied strictly as a research reference material — not for human or veterinary use.
Related peptides
Growth-hormone-releasing peptide-6
Growth-hormone-releasing peptide-2 · Pralmorelin
Ghrelin / GHSR pathway GH-release peptide
